Differential effects of antiretroviral nucleoside analogs on mitochondrial function in HepG2 cells

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 3, 2000, Pages 496-503

  Pan Zhou, Xin Ru ^a   Cui, Lixin ^a   Zhou, Xiao Jian ^a   Sommadossi, Jean Pierre ^a,c   Darley Usmar, Victor M ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CITRATE SYNTHASE; CYTOCHROME C OXIDASE; DIDANOSINE; NUCLEOSIDE ANALOG; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ARTICLE; CELL FUNCTION; CELL STRAIN HEPG2; CITRIC ACID CYCLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; GLYCOLYSIS; HUMAN IMMUNODEFICIENCY VIRUS; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY CHAIN;

ANTI-HIV AGENTS; CARCINOMA, HEPATOCELLULAR; CITRATE (SI)-SYNTHASE; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT COMPLEX IV; HUMANS; LACTIC ACID; LIVER NEOPLASMS; MICROSCOPY, ELECTRON; MITOCHONDRIA; PEPTIDES; REVERSE TRANSCRIPTASE INHIBITORS; TUMOR CELLS, CULTURED;

EID: 0033996463     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.3.496-503.2000     Document Type: Article

References (45)

1. Barile, M., D. Valenti, S. Passarella, and E. Quagliariello. 1997. 3′-Azido-3′-deoxythmidine uptake into isolated rat liver mitochondria and impairment of ADP/ATP translocator. Biochem. Pharmacol. 53:913-920.
2. Benbrik, E., P. Chariot, S. Bonavaud, M. Ammi-Said, E. Frisdal, C. Rey, R. Gherardi, and G. Barlovatz-Meimon. 1997. Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells. J. Neurol. Sci. 149:19-25.
3. Birch-Machin, M., S. Jackson, R. Singh Kler, and D. M. Turnbull. 1993. Study of skeletal muscle mitochondrial dysfunction, p. 51-69. In L. H. Lash and D. P. Jones (ed.), Methods in toxicology: mitochondrial dysfunction. Academic Press, San Diego, Calif.
4. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
5. Bridges, E. G., A. Faraj, and J.-P. Sommadossi. 1993. Inhibition of mammalian DNA polymerase-associated 3′ to 5′ exonuclease activity by 5′-monophosphates of 3′-azido-3′-deoxythymidine and 3′-amino-3′-deoxythymidine. Biochem. Pharmacol. 45:1571-1576.
6. Browne, M. J., K. H. Mayer, S. B. Chafee, M. N. Dudley, M. R. Posner, S. M. Steinberg, K. K. Graham, S. M. Geletko, S. H. Zinner, S. L. Denman, L. M. Dunkle, S. Kaul, C. Mclaren, G. Skowron, N. M. Kouttab, T. A. Kennedy, A. B. Weitberg, and G. A. Curt. 1993. 2′,3′-Didehydro-3′-deoxythymidine (d4T) in patients with AIDS or AIDS-related complex: a phase I trial. J. Infect. Dis. 167:21-29.
7. Burchell, A., R. Hume, and B. Burchell. 1988. A new microtechnique for the analysis of the human hepatic microsomal glucose-6-phosphatase system. Clin. Chim. Acta 173:183-191.
8. Casademont, J., A. Barrientos, J. M. Grau, E. Pedrol, X. Estivill. A. Urbano-Marquez, and V. Nunes. 1996. The effect of zidovudine on skeletal muscle mtDNA in HIV-1 infected patients with mild or no muscle dysfunction. Brain 119:1357-1364.
9. Chariot, P., F. Le Maguet, F. J. Authier, D. Labes, F. Poron, and R. Gherardi. 1995. Cytochrome c oxidase deficiency in zidovudine myopathy affects perifascicular muscle fibres and arterial smooth muscle cells. Neuropathol. Appl. Neurobiol. 21:540-547.
10. Chariot, P., I. Monnet, and R. Gherardi. 1993. Cytochrome c oxidase reaction improves histopathological assessment of zidovudine myopathy. Ann. Neurol. 34:561-565.
11. Chen, C. H., M. Vazquez-Padua, and Y. C. Cheng. 1991. Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity. Mol. Pharmacol. 39:625-628.
12. Cheng, Y. C., C. H. Chen, M. A. Vazquez-Padua, and M. C. Starnes. 1990. DNA polymerases versus HIV reverse transcriptase in AIDS therapy. Ann. N. Y. Acad. Sci. 616:217-223.
13. Cui, L., L. Locatelli, M. Y. Xie, and J.-P. Sommadossi. 1997. Effect of nucleoside analogs on neurite regeneration and mitochondrial DNA synthesis in PC-12 cells. J. Pharmacol. Exp. Ther. 280:1228-1234.
14. Cui, L., S. Yoon, R. S. Schinazi, and J.-P. Sommadossi. 1995. Cellular and molecular events leading to mitochondrial toxicity of 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-iodouracil in human liver cells. J. Clin. Investig. 95: 555-563.
15. Dalakas, M. C., M. E. Leon-Monzon, I. Bernardini, W. A. Gahl, and C. A. Jay. 1994. Zidovudine-induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage. Ann. Neurol. 35:482-487.
16. Dalakas, M. C., I. Illa, G. H. Pezeshkpour, J. P. Laukaita, B. Cohen, and J. L. Griffin. 1990. Mitochondrial myopathy caused by long-term zidovudine therapy. N. Engl. J. Med. 322:1098-1105.
17. Darley-Usmar, V. M., R. A. Capaldi, S. Takamiya, F. Millett, M. T. Wilson, F. Malatesta, and P. Sarti. 1987. Reconstitution and molecular analysis of the respiratory chain, p. 113-126. In V. M. Darley-Usmar, D. Rickwood, and M. T. Wilson (ed.), Mitochondria: a practical approach. IRL press, Oxford, England.
18. Davey, G. P., L. Canevari, and J. B. Clark. 1997. Threshold effects in synaptosomal and nonsynaptic mitochondria from hippocampal CA1 and paramedian neocortex brain regions. J. Neurochem. 69:2564-2570.
19. Davey, G. P., S. Peuchen, and J. B. Clark. 1998. Energy thresholds in brain mitochondria. Potential involvement in neurodegeneration. J. Biol. Chem. 273:12753-12757.
20. Dubinsky, R. M., R. Yarchoan, M. Dalakas, and S. Broder. 1989. Reversible axonal neuropathy from the treatment of AIDS and related disorders with 2′,3′-dideoxycytidine (ddC). Muscle Nerve 12:856-860.
21. Dusheiko, G. M. 1994. Fialuridine toxicity: new hopes and false downs. Int. Antiviral News 2:22-23.
22. Fortgang, I. S., P. C. Belitsos, R. E. Chaisson, and R. D. Moore. 1995. Hepatomegaly and steatosis in HIV-infected patients receiving nucleoside analog antiretroviral therapy. Am. J. Gastroenterol. 90:1433-1436.
23. Freiman, J. P., K. E. Helfert, M. R. Hamrell, and D. S. Stein. 1993. Hepatomegaly with severe steatosis in HIV-seropositive patients. AIDS 7:379-385.
24. Furman, P. A., J. A. Fyfe, M. H. St. Clair, K. Weinhold, J. L. Rideout, G. A. Freeman, S. N. Lehrman, D. P. Bolognesi, S. Broder, H. Mitsuya, and D. W. Barry. 1986. Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase. Proc. Natl. Acad. Sci. USA 83:8333-8337.
25. Gray, N. M., C. L. Marr, C. R. Penn, J. Cameron, and R. C. Bethell. 1995. The intracellular phosphorylation of (-)-2′-deoxy-3′-thiacytidine (3TC) and the incorporation of 3TC 5′-monophosphate into DNA by HIV-1 reverse transcriptase and human DNA polymerase gamma. Biochem. Pharmacol. 50:1043-1051.
26. Hobbs, G. A., S. A. Keilbaugh, P. M. Rief, and M. V. Simpson. 1995. Cellular targets of 3′-azido-3′-deoxythymidine: an early (non-delayed) effect on oxidative phosphorylation. Biochem. Pharmacol. 50:381-390.
27. Kovalenko, S. A., G. Kopsidas, J. Kelso, F. Rosenfeldt, and A. W. Linnane. 1998. Tissue-specific distribution of multiple mitochondrial DNA rearrangements during human aging. Ann. N. Y. Acad. Sci. 854:171-181.
28. Martin, J. L., C. E. Brown, N. Matthews-Davis, and J. E. Reardon. 1994. Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis. Antimicrob. Agents Chemother. 38:2743-2749.
29. Mhiri, C., M. Baudrimont, G. Bonne, C. Geny, F. Degoul, C. Marsac, E. Roullet, and R. Gherardi. 1991. Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction. Ann. Neurol. 29:606-614.
30. Mitsuya, H., and S. Broder. 1986. Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2′,3′-dideoxynucleosides. Proc. Natl. Acad. Sci. USA 83:1911-1915.
31. Miyako, K., Y. Kai, T. Irie, K. Takeshige, and D. Kang. 1997. The content of intracellular mitochondrial DNA is decreased by 1-methyl-4-phenylpyridinium ion (MPP+). J. Biol. Chem. 272:9605-9608.
32. Olano, J. P., M. J. Borucki, J. W. Wen, and A. K. Haque. 1995. Massive hepatic steatosis and lactic acidosis in a patient with AIDS who was receiving zidovudine. Clin. Infect. Dis. 21:973-976.
33. Peters, B. S., J. Winer, D. N. Landon, A. Stotter, and A. J. Pinching. 1993. Mitochondrial myopathy associated with chronic zidovudine therapy in AIDS. Q. J. Med. 86:5-15.
34. Rickwood, D., M. T. Wilson, and V. M. Darley-Usmar. 1987. Isolation and characteristics of intact mitochondria, p. 6. In V. M. Darley-Usmar, D. Rickwood, and M. T. Wilson (ed.), Mitochondria: a practical approach. IRL Press, Oxford, England.
35. Robinson, J. B., L. G. Brent, B. Sumegi, and P. A. Srere. 1987. An enzymatic approach to the study of the Krebs tricarboxylic acid cycle, p. 160-161. In V. M. Darley-Usmar, D. Rickwood, and M. T. Wilson (ed.), Mitochondria: a practical approach. IRL Press, Oxford, England.
36. Semino-Mora, C. M., M. Leon-Monzon, and M. C. Dalakas. 1997. Mitochondrial and cellular toxicity induced by fialuridine in human muscle in vitro. Lab. Investig. 76:487-495.
37. Sinnwell, T. M., K. Sivakumar, S. Soueidan, C. Jay, J. A. Frank, A. C. McLaughlin, and M. C. Dalakas. 1995. Metabolic abnormalities in skeletal muscle of patients receiving zidovudine therapy observed by 31P in vivo magnetic resonance spectroscopy. J. Clin. Investig. 96:126-131.
38. Slipetz, D. M., J. R. Aprille, P. R. Goodyer, and R. Rozen. 1991. Deficiency of complex III of the mitochondrial respiratory chain in a patient with facioscapulohumeral disease. Am. J. Hum. Genet. 48:502-510.
39. Sommadossi, J.-P., R. Carlisle, and Z. Zhou. 1989. Cellular pharmacology of 3′-azido-3′-deoxythymidine with evidence of incorporation into DNA of human bone marrow cells. Mol. Pharmacol. 36:9-14.
40. Styrt, B., and J. P. Freiman. 1995. Hepatotoxicity of antiviral agents. Gastroenterol. Clin. N. Am. 24:839-852.
41. Sundar, K., M. Suarez, P. E. Banogon, and J. M. Shapiro. 1997. Zidovudine-induced fatal lactic acidosis and hepatic failure in patients with acquired immunodeficiency syndrome: report of two patients and review of the literature. Crit. Care Med. 25:1425-1430.
42. Taanman, J. W. 1997. Human cytochrome c oxidase: structure, function, and deficiency. J. Bioenerg. Biomembr. 29:151-163.
43. Touchette, N. 1993. HBV-drug deaths prompt restudy of similar antivirals. J. NIH Res. 5:33-35.
44. Weidner, D. A., and J.-P. Sommadossi. 1990. 3′-Azido-3′-deoxythymidine inhibits globin gene transcription in butyric acid-induced K562 human leukemia cells. Mol. Pharmacol. 38:797-804.
45. Yarchoan, R., J. M. Pluda, R. V. Thomas, H. Mitsuya, P. Brouwers, K. M. Wyvill, N. Hartman, D. G. Johns, and S. Broder. 1990. Long-term toxicity/ activity profile of 2′,3′-dideoxyinosine in AIDS or AIDS-related complex. Lancet 336:526-529.